Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Damond

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 8, 2009
Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failureSophie Stegmann, Maria Elena Manea, Charlotte Charpentier, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 7, 2013
Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infectionSéverine Delarue, Emmanuelle Didier, Florence Damond, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 2021
Bictegravir pharmacokinetics in a late-presenting HIV-1-infected pregnant woman: a case reportMinh Patrick Lê, Valentine Marie Ferré, Fabienne Mazy, et al.
AIDS (London, England)|January 31, 2003
A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypesJoséphine Braun, Jean-Christophe Plantier, Marie-France Hellot, et al.
The Journal of Antimicrobial Chemotherapy|May 31, 2012
Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcomeCharlotte Charpentier, Roland Landman, Cédric Laouénan, et al.
Journal of Virological Methods|February 12, 2021
Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirementsBenoit Visseaux, Gilles Collin, Nadhira Houhou-Fidouh, et al.
Journal of Clinical Microbiology|August 6, 2005
Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assayFlorence Damond, Gilles Collin, Diane Descamps, et al.
AIDS (London, England)|September 12, 2008
Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimenBénédicte Roquebert, Laurent Blum, Gilles Collin, et al.
AIDS (London, England)|September 10, 2010
In-vitro phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitor S/GSK1349572Charlotte Charpentier, Lucile Larrouy, Gilles Collin, et al.
AIDS (London, England)|May 19, 2015
High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patientsMélanie Bertine, Charlotte Charpentier, Benoit Visseaux, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 8, 2009
Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failureSophie Stegmann, Maria Elena Manea, Charlotte Charpentier, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 7, 2013
Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infectionSéverine Delarue, Emmanuelle Didier, Florence Damond, et al.
The Journal of Antimicrobial Chemotherapy|November 18, 2021
Bictegravir pharmacokinetics in a late-presenting HIV-1-infected pregnant woman: a case reportMinh Patrick Lê, Valentine Marie Ferré, Fabienne Mazy, et al.
AIDS (London, England)|January 31, 2003
A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypesJoséphine Braun, Jean-Christophe Plantier, Marie-France Hellot, et al.
The Journal of Antimicrobial Chemotherapy|May 31, 2012
Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcomeCharlotte Charpentier, Roland Landman, Cédric Laouénan, et al.
Journal of Virological Methods|February 12, 2021
Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirementsBenoit Visseaux, Gilles Collin, Nadhira Houhou-Fidouh, et al.
Journal of Clinical Microbiology|August 6, 2005
Improved sensitivity of human immunodeficiency virus type 2 subtype B plasma viral load assayFlorence Damond, Gilles Collin, Diane Descamps, et al.
AIDS (London, England)|September 12, 2008
Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimenBénédicte Roquebert, Laurent Blum, Gilles Collin, et al.
AIDS (London, England)|September 10, 2010
In-vitro phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitor S/GSK1349572Charlotte Charpentier, Lucile Larrouy, Gilles Collin, et al.
AIDS (London, England)|May 19, 2015
High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patientsMélanie Bertine, Charlotte Charpentier, Benoit Visseaux, et al.
Pageof 12